BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 28801299)

  • 1. [Effect of bortezomib in inducing apoptosis of imatinib-resistant K562 cells and the mechanism].
    Hua JY; Zhou XH; Ouyang ST; Wu YB
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Aug; 37(8):1136-1139. PubMed ID: 28801299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro].
    Wang XD; Qiu L; Lu RZ; Chen LJ; Zhan ZM; Han BH; Zhang BL; Ma J
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3399-405. PubMed ID: 18476538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel tubulin polymerization inhibitor, MPT0B206, downregulates Bcr-Abl expression and induces apoptosis in imatinib-sensitive and imatinib-resistant CML cells.
    Chen CW; Lee YL; Liou JP; Liu YH; Liu CW; Chen TY; Huang HM
    Apoptosis; 2016 Sep; 21(9):1008-18. PubMed ID: 27344662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of Quercetin on Wnt/β-Catenin Signal Pathway of K562 and K562R Cells].
    Li W; Zhao Y; Qiu L; Ma J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1409-1415. PubMed ID: 31607291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms.
    Hekmatshoar Y; Ozkan T; Altinok Gunes B; Bozkurt S; Karadag A; Karabay AZ; Sunguroglu A
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):23-30. PubMed ID: 29808796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment of an imatinib resistance cell line K562R and its resistant principia].
    Zhu HL; Liu T; Meng WT; Jia YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):22-6. PubMed ID: 17294720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide and bortezomib interact synergistically to induce apoptosis in chronic myelogenous leukemia cells resistant to imatinib mesylate through Bcr/Abl‑dependent mechanisms.
    Xu W; Wei W; Yu Q; Wu C; Ye C; Wu Y; Yan H
    Mol Med Rep; 2014 Sep; 10(3):1519-24. PubMed ID: 24939418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect and mechanism of platycodin D combined with imatinib on K562/R].
    Dai Q; Ge YQ
    Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(2):385-389. PubMed ID: 29552859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of trichostatin alone and combination with imatinb on the proliferation and apoptosis of the K562R cells].
    Chen S; Liu Y; Zeng H; He Q; Zhao X; Chen F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 36(8):782-5. PubMed ID: 21937807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib and sphingosine kinase inhibitor interact synergistically to induces apoptosis in BCR/ABl+ cells sensitive and resistant to STI571 through down-regulation Mcl-1.
    Li QF; Yan J; Zhang K; Yang YF; Xiao FJ; Wu CT; Wang H; Wang LS
    Biochem Biophys Res Commun; 2011 Feb; 405(1):31-6. PubMed ID: 21195056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Proliferative Effects of Dendrophthoe pentandra Methanol Extract on BCR/ABL-Positive and Imatinib-Resistant Leukemia Cell Lines.
    Zamani A; Mat Jusoh SA; Al-Jamal HA; Sul'ain MD; Johan MF
    Asian Pac J Cancer Prev; 2016 Nov; 17(11):4857-4861. PubMed ID: 28030911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polymethoxyflavone from Laggera pterodonta induces apoptosis in imatinib-resistant K562R cells via activation of the intrinsic apoptosis pathway.
    Cao C; Liu B; Zeng C; Lu Y; Chen S; Yang L; Li B; Li Y; Li Y
    Cancer Cell Int; 2014; 14(1):137. PubMed ID: 25530716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization of imatinib-resistant CML cells to TRAIL-induced apoptosis is mediated through down-regulation of Bcr-Abl as well as c-FLIP.
    Park SJ; Kim MJ; Kim HB; Kang CD; Kim SH
    Biochem J; 2009 Apr; 420(1):73-81. PubMed ID: 19203346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
    Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
    Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion of IL-1β from imatinib-resistant chronic myeloid leukemia cells contributes to BCR-ABL mutation-independent imatinib resistance.
    Lee CR; Kang JA; Kim HE; Choi Y; Yang T; Park SG
    FEBS Lett; 2016 Feb; 590(3):358-68. PubMed ID: 26831735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of phenylhexyl isothiocyanate on drug-resistance to imatinib in K562/G01 cell line].
    Wu RJ; Huang YQ; Ma XD
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):149-52. PubMed ID: 23611223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.
    Wei YL; Liang Y; Xu L; Zhao XY
    Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.
    Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Carter BZ; Wang X; Shi X; Liu J
    J Hematol Oncol; 2016 Nov; 9(1):129. PubMed ID: 27884201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effect of 4-chlorobenzoyl berbamine on imatinib-resistant K562 cells in vitro and in vivo].
    Zhang YF; Xu GB; Gan YC; Xu XH; Xu RZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1997-2001. PubMed ID: 22200699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells.
    Liu J; Zhang Y; Liu A; Wang J; Li L; Chen X; Gao X; Xue Y; Zhang X; Liu Y
    Int J Mol Sci; 2016 Apr; 17(4):531. PubMed ID: 27070592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.